Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
BMC CANCER, cilt.17, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17
- Basım Tarihi: 2017
- Doi Numarası: 10.1186/s12885-017-3209-5
- Dergi Adı: BMC CANCER
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Anahtar Kelimeler: Mesothelioma, Mesothelin, Midkine, Prognosis, Biomarker, PLEURAL MESOTHELIOMA, SOLUBLE MESOTHELIN, SERUM MESOTHELIN, HYALURONIC-ACID, OSTEOPONTIN, CANCER, BIOMARKER, UTILITY, GROWTH, METAANALYSIS
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Eskişehir Osmangazi Üniversitesi Adresli: Evet
Özet
Background: We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker.